Kathy Giusti

GiustiKG (cropped)

Kathy Giusti is a prominent figure in the healthcare industry, particularly known for her significant contributions to the field of multiple myeloma research and patient advocacy. She is the founder of the Multiple Myeloma Research Foundation (MMRF), an organization dedicated to accelerating the development of treatments for multiple myeloma, a type of blood cancer that affects the plasma cells in the bone marrow.

Early Life and Education

Kathy Giusti was born in an unspecified date and location. She pursued her higher education by obtaining a Bachelor's degree in Marketing from the University of Vermont. Furthering her education, Giusti earned an MBA from Harvard Business School, which laid the foundation for her future endeavors in the pharmaceutical and healthcare industries.

Career

Before her diagnosis with multiple myeloma, Kathy Giusti had a successful career in the pharmaceutical industry, holding various positions at companies such as Merck & Co. and G.D. Searle & Company. Her experience in the industry provided her with valuable insights into drug development and marketing, which would later become instrumental in her advocacy and fundraising efforts for multiple myeloma research.

Multiple Myeloma Research Foundation (MMRF)

In 1998, after being diagnosed with multiple myeloma and finding limited options for treatment, Kathy Giusti founded the MMRF alongside her twin sister, Karen Andrews. The foundation's mission is to accelerate the search for a cure for multiple myeloma by promoting collaboration among scientists, clinicians, and industry partners to facilitate the development of new treatments.

Under Giusti's leadership, the MMRF has become one of the leading organizations in the field of multiple myeloma research, raising significant funds to support research and drug development. The foundation is known for its innovative approach to medical research, including the creation of the MMRF CoMMpass Study™, a landmark clinical study that maps the genomic profile of multiple myeloma patients to better understand the disease and personalize treatment.

Awards and Recognition

Kathy Giusti's work with the MMRF and her advocacy for cancer research have earned her numerous awards and recognition. She has been named to TIME magazine's list of the 100 most influential people in the world and has received accolades from various healthcare and business organizations for her leadership and contributions to medical research.

Personal Life

Details about Kathy Giusti's personal life, including her family and current status, are not widely publicized. However, it is known that her battle with multiple myeloma and her work with the MMRF have been deeply personal, driven by her own experiences with the disease.

Legacy

Kathy Giusti's legacy is marked by her tireless efforts to advance the field of multiple myeloma research and improve the lives of those affected by the disease. Through the MMRF, she has played a crucial role in bringing patients, researchers, and healthcare providers together to work towards a common goal of finding a cure for multiple myeloma.